- Home
- ACLX vs CGAU Comparison
ACLX vs CGAU Comparison
Compare ACLX & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACLX | CGAU |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACLX | CGAU |
|---|---|---|
| Price | $67.97 | $18.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $113.75 | $14.17 |
| AVG Volume (30 Days) | 870.4K | ★ 1.3M |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 1.10% |
| EPS Growth | N/A | ★ 236.39 |
| EPS | N/A | ★ 1.60 |
| Revenue | $35,898,000.00 | ★ $1,285,392,000.00 |
| Revenue This Year | N/A | $14.70 |
| Revenue Next Year | $309.32 | $12.63 |
| P/E Ratio | ★ N/A | $11.34 |
| Revenue Growth | N/A | ★ 2.66 |
| 52 Week Low | $47.86 | $5.41 |
| 52 Week High | $94.07 | $18.78 |
Technical Indicators
Market Signals| Indicator | ACLX | CGAU |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 78.08 |
| Support Level | $66.00 | $15.68 |
| Resistance Level | $76.50 | $18.78 |
| Average True Range (ATR) | 3.50 | 0.64 |
| MACD | 0.85 | 0.23 |
| Stochastic Oscillator | 46.58 | 90.86 |
Price Performance
Historical ComparisonAbout ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About CGAU Centerra Gold Inc.
Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.